1-12 of 12
Jianfeng Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Synergistic Killing Effect Between Vorinostat and Target of CD146 in Malignant Cells

Xiaoli Ma, Jia Liu, Jiang Wu, Xiyun Yan, Peng Wu, Yong Liu, Shuang Li, Yuan Tian, Yang Cao, Gang Chen, Li Meng, Gang Xu, Shixuan Wang, Yunping Lu, Ding Ma, Jianfeng Zhou
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (20): 4589.
https://doi.org/10.1158/1078-0432.CCR-22-2867
Published: 14 October 2022
View article titled, Correction: Synergistic Killing Effect Between Vorinostat and Target of CD146 in Malignant Cells
Open the PDF for Correction: Synergistic Killing Effect Between Vorinostat and Target of CD146 in Malignant Cells in another window
Journal Articles

Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis

Yuqin Song, Quanli Gao, Huilai Zhang, Lei Fan, Jianfeng Zhou, Dehui Zou, Wei Li, Haiyan Yang, Ting Liu, Quanshun Wang, Fangfang Lv, Haiyi Guo, Xia Zhao, Dan Wang, Pei Zhang, Yidi Wang, Lei Wang, Tengfei Liu, Yun Zhang, Zhirong Shen, Jane Huang, Jun Zhu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (6): 1147–1156.
https://doi.org/10.1158/1078-0432.CCR-21-2023
Published: 15 March 2022
View article titled, Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis
Open the PDF for Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis in another window
Includes: Supplementary data
Journal Articles

A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia

Gang An, Daobin Zhou, Shu Cheng, Keshu Zhou, Jianyong Li, Jianfeng Zhou, Liping Xie, Jie Jin, Liye Zhong, Lingzhi Yan, Haiyi Guo, Chenmu Du, Jinhua Zhong, Yiling Yu, Binghao Wu, Lugui Qiu
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (20): 5492–5501.
https://doi.org/10.1158/1078-0432.CCR-21-0539
Published: 15 October 2021
View article titled, A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia
Open the PDF for A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia in another window
Includes: Supplementary data
Journal Articles

Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase

Yuqin Song, Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Haiyi Guo, Lei Zhou, Rebecca Elstrom, Jane Huang, William Novotny, Rachel Wei, Jun Zhu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (16): 4216–4224.
https://doi.org/10.1158/1078-0432.CCR-19-3703
Published: 14 August 2020
View article titled, Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase
Open the PDF for Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase in another window
Includes: Supplementary data
Journal Articles

Editor's Note: Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells

Xiaoli Ma, Jia Liu, Jiang Wu, Xiyun Yan, Peng Wu, Yong Liu, Shuang Li, Yuan Tian, Yang Cao, Gang Chen, Li Meng, Gang Xu, Shixuan Wang, Yunping Lu, Ding Ma, Jianfeng Zhou
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1530.
https://doi.org/10.1158/1078-0432.CCR-20-0310
Published: 13 March 2020
View article titled, Editor's Note: Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells
Open the PDF for Editor's Note: Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells in another window
Journal Articles

Correction: Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability

Jianfeng Zhou, Qinglei Gao, Gang Chen, Xiaoyuan Huang, Yunping Lu, Kanyan Li, Daxing Xie, Liang Zhuang, Jingniu Deng, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (24): 7611.
https://doi.org/10.1158/1078-0432.CCR-19-3370
Published: 13 December 2019
View article titled, Correction: Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability
Open the PDF for Correction: Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability in another window
Journal Articles

Zinc Finger Nucleases Targeting the Human Papillomavirus E7 Oncogene Induce E7 Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells

Wencheng Ding, Zheng Hu, Da Zhu, Xiaohui Jiang, Lan Yu, Xiaoli Wang, Changlin Zhang, Liming Wang, Teng Ji, Kezhen Li, Dan He, Xi Xia, Dan Liu, Jianfeng Zhou, Ding Ma, Hui Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (24): 6495–6503.
https://doi.org/10.1158/1078-0432.CCR-14-0250
Published: 14 December 2014
View article titled, Zinc Finger Nucleases Targeting the Human Papillomavirus <em>E7</em> Oncogene Induce <em>E7</em> Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells
Open the PDF for Zinc Finger Nucleases Targeting the Human Papillomavirus <em>E7</em> Oncogene Induce <em>E7</em> Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells

Xiaoli Ma, Jia Liu, Jiang Wu, Xiyun Yan, Peng Wu, Yong Liu, Shuang Li, Yuan Tian, Yang Cao, Gang Chen, Li Meng, Gang Xu, Shixuan Wang, Yunping Lu, Ding Ma, Jianfeng Zhou
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (21): 5165–5176.
https://doi.org/10.1158/1078-0432.CCR-09-3174
Published: 01 November 2010
View article titled, Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells
Open the PDF for Synergistic Killing Effect between Vorinostat and Target of CD146 in Malignant Cells in another window
Includes: Supplementary data
Journal Articles

TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis

Wanhua Yang, Danfeng Luo, Shixuan Wang, Rui Wang, Rui Chen, Yan Liu, Tao Zhu, Xiangyi Ma, Ronghua Liu, Gang Xu, Li Meng, Yunping Lu, Jianfeng Zhou, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5494–5502.
https://doi.org/10.1158/1078-0432.CCR-08-0233
Published: 02 September 2008
View article titled, TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis
Open the PDF for TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis in another window
Includes: Supplementary data
Journal Articles

Adjuvant Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma

Ning Li, Jianfeng Zhou, Danhui Weng, Chenghua Zhang, Lixin Li, Beibei Wang, Yang Song, Qiang He, Dongdong Lin, Dazhi Chen, Gang Chen, Qinglei Gao, Shixuan Wang, Gang Xu, Li Meng, YunPing Lu, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5847–5854.
https://doi.org/10.1158/1078-0432.CCR-07-0499
Published: 01 October 2007
View article titled, Adjuvant Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma
Open the PDF for Adjuvant Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma in another window
Journal Articles

Reversal of the Malignant Phenotype of Cervical Cancer CaSki Cells through Adeno-Associated Virus–Mediated Delivery of HPV16 E7 Antisense RNA

Sufang Wu, Li Meng, Shixuan Wang, Wei Wang, Ling Xi, Xun Tian, Gang Chen, Ying Wu, Jianfeng Zhou, Gang Xu, Yunping Lu, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2032–2037.
https://doi.org/10.1158/1078-0432.CCR-05-2567
Published: 11 April 2006
View article titled, Reversal of the Malignant Phenotype of Cervical Cancer CaSki Cells through Adeno-Associated Virus–Mediated Delivery of HPV16 E7 Antisense RNA
Open the PDF for Reversal of the Malignant Phenotype of Cervical Cancer CaSki Cells through Adeno-Associated Virus–Mediated Delivery of HPV16 E7 Antisense RNA in another window
Journal Articles

Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability

Jianfeng Zhou, Qinglei Gao, Gang Chen, Xiaoyuan Huang, Yunping Lu, Kanyan Li, Daxing Xie, Liang Zhuang, Jingniu Deng, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8431–8440.
https://doi.org/10.1158/1078-0432.CCR-05-1085
Published: 01 December 2005
View article titled, Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability
Open the PDF for Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability in another window